Stephen M. Rodin

2016

In 2016, Stephen M. Rodin earned a total compensation of $1.6M as General Counsel and Secretary at Medicines, a 160% increase compared to previous year.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$264,792
Option Awards$552,100
Salary$425,000
Stock Awards$240,003
Other$8,632
Total$1,590,527

Rodin received $552.1K in option awards, accounting for 35% of the total pay in 2016.

Rodin also received $100K in bonus, $264.8K in non-equity incentive plan, $425K in salary, $240K in stock awards and $8.6K in other compensation.

Rankings

In 2016, Stephen M. Rodin's compensation ranked 5,965th out of 14,075 executives tracked by ExecPay. In other words, Rodin earned more than 57.6% of executives.

ClassificationRankingPercentile
All
5,965
out of 14,075
58th
Division
Manufacturing
2,164
out of 5,486
61st
Major group
Chemicals And Allied Products
710
out of 1,900
63rd
Industry group
Drugs
535
out of 1,543
65th
Industry
Pharmaceutical Preparations
419
out of 1,173
64th
Source: SEC filing on April 26, 2017.

Rodin's colleagues

We found four more compensation records of executives who worked with Stephen M. Rodin at Medicines in 2016.

2016

Clive Meanwell

Medicines

Chief Executive Officer

2016

Stuart Kingsley

Medicines

Chief Operating Officer

2016

Christopher Cox

Medicines

Chief Corporate Development Officer

2016

William O'Connor

Medicines

Chief Financial Officer

You may also like